GeneSet | Description | P Value | FDR |
---|---|---|---|
hsa04010 | MAPK signaling pathway | 2.37E-12 | 7.73E-10 |
hsa05133 | Pertussis | 3.07E-10 | 5.01E-08 |
hsa05200 | Pathways in cancer | 1.51E-09 | 1.64E-07 |
hsa05152 | Tuberculosis | 3.25E-09 | 2.65E-07 |
hsa05140 | Leishmaniasis | 6.93E-09 | 4.52E-07 |
hsa05418 | Fluid shear stress and atherosclerosis | 6.81E-08 | 3.57E-06 |
hsa04066 | HIF-1 signaling pathway | 7.67E-08 | 3.57E-06 |
hsa05145 | Toxoplasmosis | 2.00E-07 | 8.14E-06 |
hsa05162 | Measles | 6.63E-07 | 2.40E-05 |
hsa04064 | NF-kappa B signaling pathway | 9.56E-07 | 3.12E-05 |
hsa05215 | Prostate cancer | 1.10E-06 | 3.26E-05 |
hsa05142 | Chagas disease (American trypanosomiasis) | 1.55E-06 | 4.21E-05 |
hsa04919 | Thyroid hormone signaling pathway | 3.69E-06 | 9.25E-05 |
hsa04380 | Osteoclast differentiation | 7.11E-06 | 1.65E-04 |
hsa05202 | Transcriptional misregulation in cancer | 8.75E-06 | 1.90E-04 |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.91E-05 | 3.89E-04 |
hsa04151 | PI3K-Akt signaling pathway | 2.38E-05 | 4.56E-04 |
hsa04620 | Toll-like receptor signaling pathway | 2.53E-05 | 4.58E-04 |
hsa04659 | Th17 cell differentiation | 2.98E-05 | 5.11E-04 |
hsa05211 | Renal cell carcinoma | 4.26E-05 | 6.94E-04 |